Treatment of Advanced Metastatic Melanoma

The introduction in clinical practice of new drug compounds both targeted therapies anti-BRAF and checkpoint inhibitors have largely improved our potential to manage advanced metastatic melanoma patients. This has led to a significant improvement in terms of response rates and particularly in the ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Quaglino, Pietro, Fava, Paolo, Tonella, Luca, Rubatto, Marco, Ribero, Simone, Fierro, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366308/
https://www.ncbi.nlm.nih.gov/pubmed/34447613
http://dx.doi.org/10.5826/dpc.11S1a164S

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366308/
https://www.ncbi.nlm.nih.gov/pubmed/34447613
http://dx.doi.org/10.5826/dpc.11S1a164S

Ejemplares similares